Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


May 24, 2015 2:33 PM ET

Pharmaceuticals

Company Overview of Sanofi-Aventis U.S. LLC

Company Overview

Sanofi-Aventis U.S. LLC is a healthcare company that discovers, develops, produces, and markets therapeutic solutions focused on patients’ needs in the United States. The company researches, develops, and brings to market healthcare products and treatments for cardiovascular diseases, oncology, sleep disorder, thrombosis, allergy and respiratory illness, diabetes, central nervous system, internal medicine, metabolic disorders, osteoporosis, and hypertension. It offers prescription products, vaccines and biologics, and other products. The company was founded in 1999 and is headquartered in Bridgewater, New Jersey. Sanofi-Aventis U.S. LLC operates as a subsidiary of Sanofi.

55 Corporate Drive

Bridgewater, NJ 08807

United States

Founded in 1999

Phone:

908-981-5000

Fax:

908-203-7777

Key Executives for Sanofi-Aventis U.S. LLC

Chief Executive Officer of Canada Operations and President of Canada Operations
Chief Executive Officer of Sanofi-Aventis
Age: 54
Chairman of Chattem and Chief Executive Officer of Chattem
Age: 65
President of U S Science and Medical Affairs
President of North America Pharmaceuticals
Compensation as of Fiscal Year 2014.

Sanofi-Aventis U.S. LLC Key Developments

ZAI Lab Limited Signs License Agreement with Sanofi-Aventis

ZAI Lab Limited has entered into a global licensing agreement with Sanofi-Aventis U.S. LLC for two novel compounds potential treatment of chronic respiratory diseases including chronic obstructive pulmonary disease (COPD), asthma and idiopathic pulmonary fibrosis (IPF). Under the terms of the agreement, ZAI Lab will be responsible for global development, manufacturing and commercialization of the two clinical ready novel programs. Sanofi will potentially receive development and regulatory approval milestones and tiered royalties from the global net sales of the licensed products.

Sanofi North America Presents at SelectUSA 2013 Investment Summit, Oct-31-2013 02:15 PM

Sanofi North America Presents at SelectUSA 2013 Investment Summit, Oct-31-2013 02:15 PM. Venue: Washington, District Of Columbia, United States. Speakers: Anne Whitaker, CEO.

Similar Private Companies By Industry

Company Name Region
Mersana Therapeutics, Inc. United States
The Ester C Company United States
BioScriptives United States
Diamyd Inc. United States
OSR Solutions, Inc. United States

Recent Private Companies Transactions

Type
Date
Target
No transactions available in the past 12 months.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Bertelsmann AG Europe
Rush University United States
Greater Houston Partnership United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Sanofi-Aventis U.S. LLC, please visit www.sanofi-aventis.us. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.